Allan Camaisa

All filings by Allan Camaisa on record concern Calidi Biotherapeutics, Inc. The record holds 3 filings, for trades running from 26 September 2024 to 12 December 2025.

No open-market purchase appears, only 2 sales worth €16k. Other entries cover 1 share grant. Since January 2025: no purchases and 1 sale on the market.

On 16 December 2025 came the latest disclosure, an open-market sale for €1,054 in Calidi Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.